NADHX and NADPHX are hydrated and redox inactive forms of the NADH and NADPH cofactors, known to inhibit several dehydrogenases in vitro. A metabolite repair system that is conserved in all domains of life and that comprises the two enzymes NAD(P)HX dehydratase and NAD(P) HX epimerase, allows reconversion of both the S-and R-epimers of NADHX and NADPHX to the normal cofactors. An inherited deficiency in this system has recently been shown to cause severe neurometabolic disease in children. Although evidence for the presence of NAD(P)HX has been obtained in plant and human cells, little is known about the mechanism of formation of these derivatives in vivo and their potential effects on cell metabolism. Here, we show that NAD(P)HX dehydratase deficiency in yeast leads to an important, temperature-dependent NADHX accumulation in quiescent cells with a concomitant depletion of intracellular NAD + and serine pools. We demonstrate that NADHX potently inhibits the first step of the serine synthesis pathway in yeast. Human cells deficient in the NAD (P)HX dehydratase also accumulated NADHX and showed decreased viability. In addition, those cells consumed more glucose and produced more lactate, potentially indicating impaired mitochondrial function. Our results provide first insights into how NADHX accumulation affects cellular functions and pave the way for a better understanding of the mechanism(s) underlying the rapid and severe neurodegeneration leading to early death in NADHX repair-deficient children.
Introduction
A derivative of the central cofactor NADH, that differs from the normal cofactor by the absence of the typical absorbance maximum at 340 nm, had already been described to be formed in the presence of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the 1950s by Edwin Krebs and colleagues [1] . Nuclear magnetic resonance studies revealed that this derivative, called NADHX, resulted from hydration of NADH on the 5,6-double bond of the nicotinamide cycle, leading to the formation of S-and R-epimeric forms ((6S)-or (6R)-6-hydroxy-tetrahydro-NAD; designated (S)-NADHX and (R)-NADHX hereafter) Abbreviations 2HG, 2-hydroxyglutarate; 3PGA, 3-phosphoglycerate; 3PHP, 3-phosphohydroxypyruvate; 3PSER, 3-phosphoserine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KO, knockout; NAXD, NAD(P)HX dehydratase; NAXE, NAD(P)HX epimerase; OD, optical density; ORF, open reading frame; PHGDH, phosphoglycerate dehydrogenase; PSAT1, phosphoserine transaminase 1; aKG, a-ketoglutarate.
depending on the orientation of the hydroxyl group at the C-6 atom (Fig. 1A) [2] . Acidic conditions and the presence of high phosphate concentrations also stimulate NADHX formation and enhance further conversion of the latter to a third derivative (cyclic NADHX) [3] . Analogously, the phosphorylated cofactor NADPH can undergo hydration and cyclization, resulting in all three forms of NADPHX [4] . An enzymatic activity catalyzing an ATP-dependent reconversion of NADHX back to NADH had been described in yeast extracts briefly after the discovery of these noncanonical metabolites [5] , and more recently, the existence of an S-epimer specific NADHX dehydratase was proposed [6] . In 2011, the gene encoding this enzyme has been identified (designated NAXD in humans, EC 4.2.1.93) and an additional gene was shown to encode an NAD (P)HX epimerase (NAXE in humans, EC 5.1.99.6); together those genes encode an NAD(P)HX repair system that is conserved in the great majority of living species [7] (Fig. 1A) . Subsequent subcellular localization studies revealed that these enzymes are also targeted to multiple subcellular compartments including the cytosol and the mitochondria for the mouse and Arabidopsis dehydratases and epimerases as well as the endoplasmic reticulum for the mouse dehydratase and the chloroplasts for the Arabidopsis dehydratase and epimerase [8] [9] [10] . The NAD(P)HX dehydratase and epimerase are two members of a growing list of enzymes that have been recognized in recent years to participate in a process called metabolite repair or metabolite proofreading and in which a panoply of protective enzymatic activities are required to prevent the accumulation of noncanonical, potentially toxic metabolites that are formed continuously via enzymatic side reactions or spontaneous chemical reactions [11] [12] [13] [14] . The NAXE protein has been reported by other investigators to play a role in cholesterol efflux and angiogenesis [15, 16] and might be involved in vitamin B 6 metabolism in Escherichia coli [17] ; it remains unclear how these roles could be reconciled with the metabolite repair function [17, 18] .
Despite the very high degree of conservation of the NAD(P)HX repair system and its presumed role in preserving active forms of the central cofactors NAD and NADP and/or preventing accumulation of toxic derivatives thereof, no overt growth phenotypes have been identified so far in high-throughput screens with E. coli or yeast strains deleted for the NAD(P)HX repair genes [19, 20] . Similarly, no growth phenotype was observed in Arabidopsis NAD(P)HX dehydratase knockout lines maintained under standard conditions [8, 10] . In yeast, the NAD(P)HX dehydratase gene has, however, been shown to be induced by heat-shock and DNA damage (stress response element-regulated gene; [21] ) and NAD(P)HX dehydratase-deficient Bacillus subtilis mutants displayed prolonged lag phases and reduced growth rates when cultivated under potassium limitation [22] . In apparent contrast to these absent or subtle phenotypes in experimental model organisms, recent case reports from young children indicate a critical role for NAD(P)HX repair in the central nervous system. Spiegel et al. [23] described five siblings of a consanguineous family with a homozygous mutation in the human NAD(P)HX epimerase gene (NAXE). All patients presented with a severe leukoencephalopathy following trivial febrile illnesses during their first year of life. Disease progression included general weakness and loss of acquired motor skills within days until the occurrence of death at the age of 5 at the latest. In a second case report, Kremer and colleagues described very similar disease progressions with onset of symptoms after febrile infections and rapid deterioration of the health status for six children from four families carrying biallelic mutations in NAXE [24] . They also found elevated NADHX levels in fibroblasts derived from the patients. To date, no disease-causing mutations have been reported yet for the NAD(P)HX dehydratase gene (NAXD).
Despite the recent evidence for the existence of NAD(P)HX in plants and human cells [10, 24] and for the clinical importance of the NAD(P)HX repair system [23, 24] , very little is known about the intracellular reactions leading to NAD(P)HX formation as well as the effects of NAD(P)HX accumulation on metabolic pathways and other cellular processes. The aim of this study was to analyze the consequences of NAD(P)HX repair enzyme deficiency in yeast and human cells on cell growth and viability, gene expression, and metabolism and to identify factors influencing intracellular NADHX formation. We were able to show intracellular NADHX accumulation in both yeast and human cells, most importantly after the deletion of the NAD (P)HX dehydratase gene. In a yeast NAD(P)HX dehydratase knockout strain, NADHX accumulation was accompanied by a decrease in intracellular NAD + and serine levels of up to 60% compared to a wild-type control strain. We discovered that NADHX is interfering with serine metabolism in yeast by inhibiting the first step in the de novo serine synthesis pathway from 3-phosphoglycerate. While yeast NAD(P)HX dehydratase knockout cells did not show slowed growth under the conditions tested here, knocking out the NAXD gene in human cells led to a significant decrease in cell viability after prolonged cultivation times. Increased glucose consumption and lactate production in the human NAXD knockout cells also 9.5 9.6 9.7 9.8 9. If not repaired by NAD(P)HX dehydratase (yellow; NAXD in humans, Ykl151c in yeast) and/or NAD(P)HX epimerase (orange; NAXE in humans, Ynl200c in yeast), they undergo further degradation to cyclic NADHX. (B, C) Yeast strains deleted for the YKL151C and/or YNL200C genes were cultivated in minimal defined medium. NADHX derivatives were extracted around 5.5 h (B) or 1 h (C) after entering the postdiauxic phase using a method adapted from Sporty et al. [25] . Cell extracts were analyzed by HPLC-UV and NADHX peaks were identified based on retention time and UV absorption spectrum in comparison to purified standards. (B) For each strain, a representative chromatographic peak at the expected retention time is shown in the upper panels. A mobile phase 'blank' run (50 mM ammonium acetate, pH 7.0) is also shown as a background control (continuous blue line). The UV absorption spectra of the NADHX derivatives in a ykl151cD mutant extract are overlaid with the spectra of the corresponding standards (lower panels). A contaminating compound present in yeast extracts in postdiauxic phase coelutes with (R)-NADHX, causing a slight shift of the absorption spectrum of the corresponding peak from the standard spectrum. Values shown in (C) are means AE SD of three (ykl151cD) or four (wild-type, ynl200cD, ykl151cDynl200cD) independent replicates. Statistical significance was calculated using an equal variance, unpaired Student's t-test. In strains deleted for the YKL151C gene, concentrations of (S)-, (R)-, and cyclic NADHX were significantly increased. In the ynl200cD strain, the only significantly changed NADHX derivative was the cyclic form. (*P < 0.05; **P < 0.01, ***P < 0.001). A 279 , absorbance at 279 nm.
provided a preliminary indication for perturbed mitochondrial function in those cells.
Results

NAD(P)HX dehydratase deficiency leads to NAD (P)HX accumulation and NAD + depletion in yeast
Given that little is known about the formation and effects/roles of NADHX and NADPHX in living cells, our first aim was to study the consequences of NAD (P)HX dehydratase and/or epimerase deficiency on the intracellular levels of normal and damaged forms of the nicotinamide nucleotide cofactors in the simple eukaryotic model organism Saccharomyces cerevisiae. Yeast deletion mutants lacking the NAD(P)HX dehydratase gene (YKL151C), the NAD(P)HX epimerase gene (YNL200C), or both genes were cultivated in minimal defined medium supplemented with 2% D-glucose along with the wild-type strain (all strains were isogenic to BY4741). Metabolites were extracted according to our protocol adapted from Sporty et al. [25] at different stages of growth for subsequent analysis of NAD + , NADH, and NADHX derivatives by HPLC-UV. Based on retention time and UV absorption spectrum comparison with standard compounds, we could detect (S)-, (R)-, and cyclic NADHX in all cell extracts, independently from the strain and for most of the sampling points, even though for some samples in only very small amounts (Fig. 1B) . Strikingly, in postdiauxic phase cells, (S)-, (R)-, and cyclic NADHX were found to accumulate to high levels in the ykl151cD and ykl151cDynl200cD strains (Fig. 1C ) (ykl151cD mutant and ykl151cDynl200cD vs. WT ratios > 40 for all NADHX derivatives), but not significantly (P > 0.05; apart from cyclic NADHX, P = 0.031) in the ynl200cD strain (ynl200cD mutant vs. WT ratios of 4.8, 1.4, and 2.8 for (S)-NADHX, (R)-NADHX, and cyclic NADHX, respectively) (Fig. 1C) . The absence of significant NADHX accumulation in the ynl200cD strain (as also observed during exponential growth; not shown) suggested that, under the conditions tested, spontaneous intracellular epimerization between (R)-and (S)-NADHX and the presence of the NAD(P)HX dehydratase were sufficient to prevent NADHX from building up. Similar results were obtained for all four strains using an LC-MS method for NADHX analysis based on retention time and accurate mass for compound identification [10] (Fig. 2A) . Using this LC-MS method, NADPHX could also be detected (although with lower signal intensities and reproducibility) and was also Wild-type, NAD(P)HX epimerase deficient (ynl200cD), and NAD(P)HX dehydratase deficient (ykl151cD) as well as yeast cells deficient in both enzymes (ykl151cDynl200cD) were sampled around 1 h into postdiauxic phase. Metabolites from~5 mg (wet weight) of cells were extracted and analyzed by LC-MS using retention time and accurate mass for compound identification as described in Niehaus et al. [10] . Graphs show means AE SD of six biological replicates. Statistical significance was determined using an equal variance, unpaired Student's t-test. P-values were determined for all NAD(P)HX derivatives individually (compared to the wild-type) (*P < 0.05, **P < 0.01, ***P < 0.001). shown to accumulate in the NAD(P)HX dehydratase deficient strains, but to a much lesser extent in the ynl200cD strain (Fig. 2B) . In contrast to the results obtained (for NADHX) by HPLC-UV, the cyclic NAD(P)HX derivatives were the predominant forms detected using the LC-MS method, which may at least partially be explained by slow cyclization of (S)-and (R)-NAD(P)HX during the longer sample storage durations before LC-MS analysis, as also suggested previously [10] . Taken together, these results indicated that hydration of both NADH and NADPH can occur intracellularly and that the Ykl151c dehydratase is the main enzyme responsible to limit NAD(P)HX accumulation under standard cultivation conditions in yeast. Also, based on these results, we decided to focus for the rest of this study on the ykl151cD strain. As can be seen in Fig. 3A , the wild-type and ykl151cD strains presented identical growth properties under the cultivation conditions used (300 mL cultivations grown in minimal defined medium with 2% glucose in 2 liter flasks at 30°C under continuous shaking). Similarly, no difference in growth rate or biomass yield between the two strains was found in more than 170 additional environmental conditions tested (in 96-and 384-well plate microcultivation format, shaking flasks, and/or agar plates) including the presence of various chemical stressors (e.g., methanol, ethanol, dithiothreitol, glycolaldehyde), exposure to different temperatures (continuously, at 25-37°C; short-term, < 180 min, at 30-70°C), and replacement of glucose with different carbon sources (e.g., glycerol, pyruvate, galactose; also in combination with other stresses). The list of all the environmental conditions tested is given in Table S1 . Inoculation of main cultures from postdiauxic and stationary phase cultures instead of exponentially growing cultures also did not lead to a detectable growth phenotype of the ykl151cD strain compared to the wild-type strain (Table S1 ).
Based on our initial NAD(P)(H)(X)-profiling results, showing, in contrast to the growth behavior, clear differences between the wild-type and ykl151cD strains, we next repeated those measurements in a time-course experiment where metabolites were extracted during exponential growth, at the entrance of postdiauxic phase, and 5.5 h into postdiauxic phase (as shown in Fig. 3A ). In the exponential growth phase, only very low levels of total NADHX (sum of (S)-, (R), and cyclic NADHX) were detected in both strains, but a slight increase was observed in the ykl151cD strain (3.5-fold for (S)-, 1.5-fold for (R)-, and 2.8-fold for cyclic NADHX, Fig. 3B and E). On entrance into postdiauxic phase, accompanied by glucose depletion and decreased cell division rate, similarly low NADHX levels were still found in the wild-type strain; in contrast, the total NADHX levels measured in the ykl151cD strain had increased more than 16-fold compared to exponential growth ( Fig. 3C and E) . In this same strain, it could also clearly be seen that the relative abundance of the different NADHX derivatives was growth phase dependent. Although the cyclic form of NADHX, which is derived from the S-and R-epimers of NADHX [7] , represented a minor fraction of the total NADHX measured at the beginning of the postdiauxic phase, this derivative represented the predominant fraction later in postdiauxic phase ( Fig. 3D and E). While we currently ignore the precise reasons underlying this growth phase-dependent NADHX profile in the ykl151cD strain, decreased cell proliferation and switch from fermentative to respiratory metabolism may both contribute to NADHX accumulation becoming apparent only in postdiauxic phase.
The increase in NADHX levels was accompanied by a decrease in NAD + levels in the ykl151cD strain ( Fig. 3D and F) . While this decrease was only moderate and not statistically significant (P = 0.45) during Fig. 3 . NADHX accumulates during the postdiauxic phase in yeast strains lacking the NAD(P)HX dehydratase Ykl151c. An NAD(P)HX dehydratase-deficient (ykl151cD) strain and a wild-type strain were cultivated in minimal defined medium containing uracil (A-F) or no uracil (G). NAD(H) and NADHX derivatives were extracted at different stages of growth using methods adapted from Sporty et al. [25] (B-F) or from Becker-Kettern et al. [37] (G) and measured by HPLC-UV. Growth was followed by measuring absorbance at 600 nm (A) and dashed lines indicate the sampling points (B-G); in (G), measurements correspond to the late postdiauxic phase time point. (B-D) For each strain and growth phase, two representative HPLC chromatograms are shown. For (E) and (F), HPLC peak areas are shown, whereas for (G), the total biovolume of extracted yeast cells was determined as described in the Methods section, allowing for calculation of intracellular concentrations. All values shown in (E-G) are means AE SD of three independent replicates. Statistical significance was calculated using an equal variance, unpaired Student's t-test. (S)-, (R)-, and cyclic NADHX level increases in the ykl151cD strain vs. wild-type strain were all significant (P < 0.004) in postdiauxic phase. During exponential growth, only the (S)-NADHX concentration was significantly increased in the ykl151cD vs. wild-type strain (P = 0.014) (see magnified inset in panel E). For clarity, statistical significance is not indicated in this figure for the NADHX derivatives, but for NAD + and NADH, statistically significant differences compared to the wild-type strain are indicated by asterisks (**P < 0.01, ***P < 0.001; A279, absorbance at 279 nm).
exponential growth, a 30% and more than 60% decrease in NAD + levels in the ykl151cD strain compared to the wild-type strain were measured in early and late postdiauxic phase, respectively. The metabolic phenotypes (NADHX accumulation as well as NAD + depletion) described above for the ykl151cD strain could be reverted by restoring YKL151C expression in this deletion mutant (Fig. 3G) . While a ykl151cD strain transformed with an empty control vector accumulated 93 lM, 64 lM, and 110 lM of (S)-, (R)-, and cyclic NADHX, respectively, the total NADHX levels measured in the wild-type control and rescue strains remained below 5 lM (Fig. 3G, left  panel) . Similarly, the more than 40% drop in NAD + levels measured in the ykl151cD strain compared to the wild-type strain (from about 1.4 mM to less than 0.8 mM) was completely prevented in the rescue strain (Fig. 3G , middle panel). These results confirmed that both NADHX accumulation and NAD + depletion were caused specifically by the YKL151C gene deletion and not by a secondary mutation in another gene of the ykl151cD strain. No significant difference between the ykl151cD and wild-type strains was found for NADH levels (Fig. 3G , right panel and Table 1 ). NADHX repair deficiency thus seems to cause depletion of the NAD + pool in the yeast cell, while NADH levels can be maintained by a presently unknown mechanism. This led to a decrease in the NAD + /NADH ratio in the ykl151cD strain, which was most pronounced in the late postdiauxic phase ( Table 1) .
Effect of temperature on intracellular NADHX levels in yeast NAD(P)HX formation from NAD(P)H is known to be accelerated by increased temperature and by the presence of glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12) in vitro [1, 2, 7] . In addition, Ykl151c has been reported as a stress-induced protein [21] and the expression of both the YKL151C and YNL200C genes is increased upon exposure to elevated temperatures [26] . We therefore wanted to test whether changes in temperature and expression of GAPDH also modulate NADHX levels in the living cell.
As shown in Fig. 4A , shifting the cultivation temperature from 30°C to 37°C led to an about 1.5-fold increase for both the (S)-and (R)-NADHX levels in ykl151cD cells. No significant decrease in NADHX levels was observed when cells were exposed to a lower temperature (25°C). Here, it should be noted that in wild-type extracts prepared shortly after the diauxic shift, a compound coeluting with (R)-NADHX (but with a different UV absorption spectrum) interfered with our (R)-NADHX measurements. In the ykl151cD strain, however, the predominant compound eluting at this retention time was (R)-NADHX, as confirmed by the UV absorption spectrum (Fig. 1B) . Assuming that the contaminant was present in similar amounts in both strains, (S)-and (R)-NADHX were detected in the ykl151cD mutant strain in a ratio (65 : 35) consistent with previously reported in vitro results [2] , when considering corrected (R)-NADHX levels. The increase in NADHX accumulation at 37°C in the ykl151cD strain was accompanied by a more pronounced decrease in intracellular NAD + levels in this strain compared to the wild-type strain at this higher temperature ( Fig. 4B ), which further supports that repair of damaged NADH is important for maintaining the functional NAD + pool. The NADHX repair capacity of the yeast cells did not seem to be exceeded under the conditions tested, as no increase of the NADHX levels was observed in the wild-type cells even at 37°C, possibly also due to the induction of the NADHX repair enzymes by the heat stress. Our results in the yeast model corroborate recent observations in patients deficient in the NAXE gene (encoding the NAD(P)HX epimerase) [23, 24] , where severe disease onset followed in general trivial febrile episodes, indicating that temperature plays a pivotal role in modulating intracellular NADHX levels, especially when the NADHX repair system is deficient.
To test whether GAPDH serves as an in vivo source for NADHX, as suggested by previous in vitro observations [1] , we tried to individually overexpress the three yeast GAPDH isoforms (encoded by the TDH1, TDH2, and TDH3 genes in yeast), using a plasmid-based system, in the ykl151cD background. The Tdh isoforms display very similar amino acid sequences and comparable kinetic properties [27] . However, in exponentially growing cells, Tdh2 and Tdh3 are the major isoforms, accounting for almost 90% of the total GAPDH activity [27] , whereas Tdh1 represents the predominant isoform in stationary phase [28] . Tdh1, but not Tdh2 or Tdh3, was also reported to be induced upon accumulation of cytosolic NADH [29] . For reasons that remain unclear, we were unable, however, despite testing the three yeast Tdh isoforms, two different overexpression systems (based either on the pAG416-GPD-ccdB vector (Addgene ID #14148, constitutive GPD promoter, low copy number, URA3 for plasmid selection) or the pAG426-GAL1-ccdB vector (Addgene ID #14155, inducible GAL1 promoter, high copy number, URA3 for plasmid selection)) and different cultivation conditions (minimal medium and synthetic complete medium; the presence of 2% galactose in case of the GAL1 vector), to induce a robust increase in expression of this enzyme in our yeast strain (as tested by western blotting) and did therefore not further pursue our attempts to validate GAPDH as a potentially major source of intracellular NADHX production. The relative contribution, if any, of Tdh isoforms to endogenous NADH hydration could also be explored using the opposite approach, that is, deletion of one or more of the TDH genes in the ykl151cD background. Other NAD-dependent enzymes should, however, be considered as well as potential endogenous sources for NADHX in future work. . NADHX levels increase at elevated temperature. Wild-type and ykl151cD mutant strains were cultivated in minimal defined medium with 2% glucose at 25°C, 30°C, or 37°C. Metabolites were extracted around 2 h into postdiauxic phase using a method adapted from [25] . NAD + and NADHX derivatives were analyzed by HPLC-UV. The values shown are means AE SD of four biological replicates.
Statistical significance was calculated using an equal variance, unpaired Student's t-test to compare NADHX levels in the ykl151cD mutant at different temperatures (A), or NAD + levels between wild-type and ykl151cD mutant (B); *P < 0.05; **P < 0.01, ***P < 0.001; n.s., not significant.
Impact of intracellular NADHX accumulation on gene expression and amino acid levels in yeast
Given the central roles of the NAD(P) cofactors in metabolism but also the regulation of gene expression via NAD-dependent histone deacetylases (sirtuins), the above-described metabolic changes caused by NAD(P) HX repair deficiency could be expected to affect a panoply of downstream cellular processes. More specifically, NADHX and NADPHX have already been shown to potently inhibit, in vitro, glycerol-3-phosphate dehydrogenase (EC 1. [32] were not taken into account for the presented data analysis) showed significantly changed expression levels (P < 0.05 based on an equal variance, unpaired Student's t-test) in the ykl151cD strain compared to the wild-type strain at the first and second time point, respectively ( Fig. 5A and Table S2 ). Gene ontology (GO) enrichment analyses, performed separately for the significantly up-and downregulated genes at both time points using the GOTermFinder tool [34] , failed to identify a specific biological process, molecular function, or cellular component significantly linked to NAD(P) HX repair deficiency. We also carried out a differential pathway analysis on metabolic pathways from the YeastCyc database (https://yeast.biocyc.org) for both time points, adjusting the significance scores for multiple hypothesis testing using the Benjamini-Hochberg method. Including only pathways with 10 or more mapped genes, the 'lipid-linked oligosaccharide biosynthesis' pathway (adjusted P-value = 0.02) and the pentose phosphate pathway (adjusted P-value = 0.06, i.e., just above the statistical significance threshold) were found to be downregulated in the ykl151cD mutant strain. Ranking the significantly (P < 0.05) changed genes according to the absolute log 2 ratio of wild-type over ykl151cD mutant, the three most differentially expressed genes (all downregulated in the ykl151cD strain) at both time points were YKL15 1C (i.e., the gene deleted in the ykl151cD strain), CHA1, and HTB2 (Table 2) . Given the high wild-type/ykl151cD-fold changes, at both time points tested, for CHA1 (>7-fold), encoding a serine (threonine) deaminase (EC 4.3.1.17), and for HTB2 (>3.8-fold), encoding the core histone protein H2B, we decided to focus on these genes for further investigations.
Decreased CHA1 expression in the ykl151cD mutant was confirmed by using a qPCR approach (Fig. 5B) . Interestingly, this downregulation was only observed during the two postdiauxic phase time points analyzed (3-and 5.5-fold decrease in CHA1 expression at the early and late postdiauxic phase time point, respectively) and not during exponential growth (Fig. 5B) , correlating therefore perfectly with the dynamics of NADHX accumulation observed previously in the ykl151cD mutant (see Fig. 3E ). In the rescue strain, wild-type levels of CHA1 were detected at all time points analyzed, confirming that the downregulation of this gene is specifically induced by the YKL151C gene deletion (Fig. 5B) . By contrast, for reasons that remain uncertain, the HTB2 downregulation found by the tiling array analyses in the ykl151cD mutant could so far not be validated by qPCR (Fig. 5C ) and we therefore did not pursue our investigations on a possible link between the HTB2 and YKL151C genes further in this study.
As CHA1, a deaminase involved in serine and threonine catabolism [35] , showed strongly decreased expression levels in the ykl151cD mutant, we wanted to investigate whether amino acid levels in general, and serine and threonine levels more specifically, were modified in this strain. Among the 20 amino acids measured, five showed significant (P < 0.05) differences in the ykl151cD versus wild-type strains (> 10% decrease) in early postdiauxic phase that were at least partially rescued upon reexpression of YKL151C in the ykl151cD background (Table S3 ). While the changes measured for glycine, asparagine, lysine, and proline were only moderate (< 20% decrease in ykl151cD versus wild-type strains), a more than 50% decrease in serine levels was measured in the ykl151cD mutant (Fig. 5D) . A similar serine depletion was measured later in postdiauxic phase, while no difference in serine levels between wild-type and ykl151cD strains was detected in exponentially growing cells, mirroring again perfectly the growth stage-dependent effects of YKL151C deletion on both NADHX levels and CHA1 expression and suggesting a causal link between these molecular phenotypes. Wild-type serine levels were measured in the rescue strain at all time points (Fig. 5D ) confirming that also serine depletion is specifically mediated by YKL151C deletion.
NADHX potently inhibits the first step of the serine synthesis pathway in yeast
The main metabolic pathway for serine synthesis in yeast growing on glucose proceeds from the glycolytic intermediate 3-phosphoglycerate (3PGA) via oxidation to 3-phosphohydroxypyruvate (3PHP) by Ser3 or Ser33, followed by transamination to 3-phosphoserine (3PSer) by Ser1, and eventually dephosphorylation by Genes with significantly (P < 0.05) different expression levels between wild-type and ykl151cD mutant strains were identified at two sampling points in early (tp1) and late (tp2) postdiauxic phase (white/gray circles, upper part) using transcriptomics analyses based on tiling arrays. Blue and yellow circles represent the number of genes that are downregulated and upregulated, respectively, in the ykl151cD versus wild-type strains. (B-D) Wild-type and ykl151cD mutant strains were transformed with an empty control plasmid or with a rescue plasmid containing the YKL151C coding sequence and cultivated in minimal defined medium with 2% glucose and without uracil. Transcript levels were determined at the indicated growth stages by qRT-PCR for the CHA1 (B) and HTB2 (C) genes. Fold changes were calculated using the 2 ÀDDCT method and ALG9 as the reference gene. (D) Intracellular serine concentrations were determined at the same growth stages using LC-MS/MS. All values shown in (B-D) are means AE SD of three biological replicates. Statistically significant differences compared to wild-type control were determined applying an equal variance, unpaired Student's t-test. *P < 0.05; **P < 0.01, ***P < 0.001.
Ser2 [36] (Fig. 6A , upper panel). Ser3 and Ser33 are two isozymes, currently annotated as NAD + -dependent 3PGA dehydrogenases (EC 1.1.1.95) based on sequence similarity with established 3PGA dehydrogenases from other species and serine auxotrophy of a ser3Dser33D double mutant [36] . As they catalyze the only supposedly NAD(P)-dependent step in this metabolic pathway, they appeared as the most plausible targets for an inhibitory effect of NADHX which could mediate the observed decrease in serine levels in the ykl151cD mutant. To test this hypothesis, we wanted to assay the enzymatic activity of recombinant Ser3 and Ser33 in vitro in the absence or presence of purified NADHX. As described in a previous publication, while we could detect an NADH-dependent a-ketoglutarate (aKG) reductase activity (producing D-2-hydroxyglutarate) with the purified yeast Ser3 and Ser33 enzymes, detecting the presumed physiological activity (NAD-dependent oxidation of 3PGA) proved much more difficult if not impossible [37] . This apparent lack of detectable 3PGA dehydrogenase activity of the Ser3 and Ser33 enzymes was reminiscent of the difficulties that other investigators had reported while trying to assay an NAD-dependent oxidation of 4-phosphoerythronate (structurally very close to 3PGA, with just one additional secondary alcohol group in the carbohydrate backbone) with the E. coli PdxB enzyme (EC 1.1.1.290) [38] . PdxB catalyzes the second step of the pyridoxal phosphate synthesis pathway in E. coli, with the subsequent step consisting in a glutamate-dependent transamination, just as the reaction following 3PGA oxidation in the serine synthesis pathway (Fig. 6A) . It is also of note that E. coli PdxB shows 27% sequence identity with the yeast Ser3 and Ser33 proteins and that the latter are the best protein hits when blasting the E. coli PdxB sequence against the S. cerevisiae genome. It was eventually shown that PdxB is actually a nicotino-enzyme that tightly binds the NAD(H) cofactor and that depends on the presence of a-ketoacid acceptors (a-ketoglutarate, oxaloacetate, Table 2 . Top 10 significantly changed genes with most different expression levels between wild-type and ykl151cD strains. Genomewide expression levels were determined in wild-type and ykl151cD strains using tiling array technology. Significantly changed genes (P < 0.05) were ranked according to absolute log 2 ratios of wild-type over knockout, reflecting-fold changes between the two strains. The upper and lower halves of the table represent results obtained for the first sampling point in early postdiauxic phase and the second sampling point in late postdiauxic phase, respectively. The P-values were calculated based on background-corrected log 2 or pyruvate) to recycle enzyme-bound reduced NADH after 4-phosphoerythronate oxidation [38] . Taken together, these observations led us to test whether Ser3 and Ser33 act as transhydrogenases to oxidize 3PGA to 3PHP with a concomitant reduction of a-ketoglutarate to 2-hydroxyglutarate, rather than acting as dehydrogenases depending on exogenous NAD + (Fig. 6A) . Indeed, in a coupled endpoint assay including the Ser3 or Ser33 enzyme as well as the human 3-phosphoserine aminotransferase homolog PSAT1 (EC 2.6.1.52; to pull the thermodynamically unfavorable 3PGA oxidation reaction [39] ), we were able, using LC-MS/MS for compound identification and quantification, to demonstrate a stoichiometrically balanced consumption of 3PGA and formation of 2-hydroxyglutarate in the presence of a-ketoglutarate and in the absence of externally added NAD + (Fig. 6B) . A more detailed characterization of this newly identified enzyme activity for Ser3 and Ser33 and its significance for yeast central carbon metabolism will be published in a separate article as it goes beyond the scope of the present study.
Having found conditions under which we could assay 3PGA oxidation by Ser3 and Ser33 in vitro, we were now in a position to test whether NADHX can inhibit the first step of the serine synthesis pathway in yeast. Purified (S)-, (R)-, or cyclic NADHX were added to the Ser3/Ser33 transhydrogenase assay at a final concentration of up to 25 lM. Specific activities were calculated based on 2-hydroxyglutarate formation measured by LC-MS/MS. As shown in Fig. 6C , the S-and R-epimers of NADHX and to a lesser extent cyclic NADHX potently inhibited Ser33 activity. Complete inhibition of the latter was reached with 0.5 lM (S)-or (R)-NADHX, while 10 lM cyclic NADHX were required to fully block this activity. By contrast, a modest stimulation of up to 1.2-fold of the activity was observed in the presence of NAD + ; this effect may be explained by a gradual partial release of the bound NAD cofactor from the purified enzyme during incubation at 30°C. It should be noted that during these enzyme assays performed at neutral pH, a certain interconversion of the S-and R-epimers of NADHX is expected due to a spontaneous epimerization reaction [7] . Nevertheless, the curves obtained when adding purified (S)-or (R)-NADHX to the assays suggest that both epimers exert strong inhibitory effects, while cyclic NADHX is a less potent inhibitor. Similar results were found with the second isoenzyme Ser3 when testing the effects of (S)-, (R)-, or cyclic NADHX as well as NAD + on the 3PGA-a-ketoglutarate transhydrogenase activity (data not shown).
Taken together our observations suggest that, in the ykl151cD mutant, the high intracellular NADHX levels measured in postdiauxic phase cells strongly inhibit the first step of the 3PGA serine synthesis pathway, leading to decreased intracellular levels of this amino acid. Reduced serine levels may in turn explain the lower CHA1 transcript levels measured in the ykl151cD mutant, as expression of this gene is known to be regulated by serine availability [40, 41] .
Human cells are more sensitive to intracellular NADHX accumulation than yeast cells
The metabolic perturbations observed upon NAD(P) HX dehydratase deletion in yeast did not lead to any detectable growth phenotype under the cultivation conditions that we have tested so far. This is in apparent contrast with recent reports, where mutations in the other NAD(P)HX repair enzyme (NAD(P)HX epimerase encoded by the NAXE gene in humans) led to severe neurometabolic symptoms and early death in affected children [23, 24] . We therefore proceeded to investigate human cells deficient in the NAD(P)HX repair enzymes. We used HAP1 haploid cell lines that had been genetically modified by the CRISPR/Cas9 technology to disrupt the human homologs of the yeast YKL151C or YNL200C genes, that is, NAXD or NAXE, respectively. Gene disruption was verified by sequencing of the corresponding genes using genomic DNA extracted from the cells. In silico translation from the residual gene sequences predicted early truncation and therefore most likely nonfunctional expression products for both genes. In the NAXD KO cell line, the mutated NAXD gene encodes a truncated protein containing the first 126 amino acids (out of the 329 amino acids of the native mitochondrial isoform) followed by nine non-native amino acids. In the NAXE KO cell line, expression of a truncated protein comprising the first 83 of the 288 amino acids of the native mitochondrial protein, followed by four nonnative amino acids, can be predicted.
Wild-type and KO HAP1 cells were cultivated in 6-well plates for 5 days and cell number and viability were determined daily. After 72 h of cultivation, a total number of about 3 million cells per well was reached for each cell line, with an average viability higher than 98% (Fig. 7A) . Strikingly, while the cell number continued to steadily increase thereafter for the control and NAXE KO cell lines, reaching more than 12 million viable cells/well after 120 h of cultivation, this increase was much more modest for the NAXD KO cell line (about 6.6 million viable cells/well after 120 h). This suggested that NAD(P)HX dehydratase, but not NAD(P)HX epimerase deficiency, negatively impacts cellular health in the tested human cell line, leading to reduced cell proliferation and/or increased death rates, phenotypes that had not been observed in the yeast system.
Using our HPLC method, we also determined NADHX levels in metabolite extracts prepared 72, 96, and 120 h after seeding the human cells. Analogous to the ykl151cD mutant, we found highly elevated levels of each NADHX derivative in the NAXD KO compared to the control cell line, but unlike for the yeast cells, the total amount of NADHX and the ratios of (S)-/(R)-NADHX versus cyclic NADHX seemed relatively independent from the sampling time point (Fig. 7B) . (S)-and (R)-NADHX represented together more than 80% of the total NADHX measured at all time points and only minor amounts of cyclic NADHX were detected. A much more modest, but often significant accumulation of (S)-, (R)-, and cyclic NADHX was also observed in the NAXE KO cell line compared to the control cell line (Fig. 7C) . However, in contrast to the NAXD KO, cyclic NADHX alone accounted for more than 33% of the total NADHX and together with (R)-NADHX summed up to more than 70% of the total NADHX in the NAXE KO at least at the first two time points. Comparing the HPLC peak areas (normalized to the cell numbers), we estimated a more than 21-fold increase and a more than 3-fold increase for each of the NADHX derivatives in the NAXD and NAXE KO cell lines (except for (R)-NADHX after 120 h in the NAXE KO, a measurement that was also not significant), respectively, compared to the control cells at each of the sampling points. At the 96 h time point, this increase corresponded to more than 87-fold for the NAXD KO line. For the latter, using estimated intracellular volumes in our samples based on measurements of the average cell diameter at the respective sampling points with the NucleoCounter NC-3000, we calculated intracellular concentrations of about 51.0 (AE 4.9) lM, 23.3 (AE 2.4) lM, and 7.4 (AE 0.7) lM (S)-, (R)-, and cyclic NADHX, respectively, after 72 h of cultivation and of about 73.8 (AE 4.3) lM, 37.4 (AE 0.7) lM, and 30.0 (AE 0.4) lM (S)-, (R)-, and cyclic NADHX, respectively, after 96 h of cultivation (values are means AE SDs for n = 3 biological replicates). Due to the low peak areas detected for the control and NAXE KO cell lines, this type of absolute NADHX quantification could not be performed for these cell lines. The levels to which NADHX accumulated in our human NAD(P)HX dehydratase KO cells were in good agreement with the ones measured for the ykl151cD mutant. As opposed to the yeast system, however, a significant NADHX accumulation could also be detected in NAD(P)HX epimerase deficient human cells. Also, in contrast to our results in the ykl151cD mutant, we did not detect any significant changes in NAD + levels in the NAD (P)HX repair-deficient KO cell lines compared to the control cells (Fig. 7D) .
Additionally, in the cultivation conditions used for the human cell lines, we could so far not detect the decrease in intracellular serine levels that we had found in the yeast cells upon deletion of the NAD(P)HX dehydratase gene. It should be noted, however, that, while our yeast cells were cultivated in a minimal medium lacking serine, the medium used for the human cell cultivations had an initial serine concentration of about 360 lM. A potential inhibition of the endogenous 3PGA serine synthesis pathway by NADHX may therefore be compensated by increased uptake of extracellular serine in the human cell cultivation system. Alternatively, it could be that the human 3PGA dehydrogenase (PHGDH) is not inhibited by NADHX. Accordingly, we confirmed that human PHGDH acts as an NADdependent dehydrogenase, as previously shown by others [42] , but we also found that it lacks the transhydrogenase activity identified in the present study for the yeast homologs of the enzyme (Ser3 and Ser33). In preliminary spectrophotometric assays of the 3PGA dehydrogenase activity of human recombinant PHGDH (coupled to the PSAT1 reaction) based on monitoring NADH production at 340 nm, neither of the NADHX derivatives ((S)-, (R)-, or cyclic NADHX tested up to a concentration of 100 lM) inhibited this enzymatic activity when tested in the presence of 50 lM 3PGA and 50 lM NAD + (data not shown). Finally, as NADHX accumulation only became detectable in postdiauxic phase (i.e., upon depletion of extracellular glucose) in the yeast model, we determined the glucose and lactate concentrations in the medium of our human cell cultures. In control HAP1 cell cultivations, the extracellular glucose concentration dropped from an initial concentration of about 22.5 mM to about 12.6 mM (after 72 h) and about 8.1 mM (after 96 h). Strikingly, when normalizing glucose consumption between 72 and 96 h to the number of cells formed in this time interval, we observed a twofold higher glucose consumption for the NAXD KO cells than for the control and NAXE KO cells (Fig. 7E ). In addition, we estimated a 2.7-fold higher lactate production for the NAXD KO cells than for the other two cell lines during that same period (Fig. 7E ). These observations indicated that the relatively high intracellular NADHX levels accumulating in the absence of an NAD(P)HX dehydratase activity lead to an increased glycolytic flux, potentially to compensate for decreased ATP production due to mitochondrial dysfunction. In this study, we show for the first time that NAD(P) HX can be formed in yeast cells and confirm that these damaged cofactors can also be formed in cultured human cells. These results, obtained in S. cerevisiae and the human near-haploid cell line HAP1, corroborate previous ones obtained in A. thaliana [10] and human fibroblasts [24] . While NADHX levels were low or barely detectable in wild-type cells, deletion of the NAD(P)HX dehydratase gene led to high accumulations of the NADH hydrates, reaching intracellular concentrations determined in our study to be in the 100-200 lM range in yeast and in human cells. Deletion of the NAD(P)HX epimerase gene led to more moderate, but detectable increases in NADHX levels in human cells, but not in our yeast model. It thus seems that, in the latter, the spontaneous epimerization rate between the (S)-and (R)-NADHX forms was not limiting efficient repair by the dehydratase alone. As spontaneous interconversion of the S-and R-epimers is highly accelerated by even a moderate decrease in pH from 7 to 6 in vitro [6] , acidification during our yeast cultivations in nonbuffered minimal media could be one reason for the dispensability of the epimerase under these conditions: the intracellular pH of yeast cells in comparable cultivations was found to be around 6.4 [43] . Using LC-MS, we also detected higher NADPHX levels in the yeast NAD(P)HX dehydratase deletion mutant ykl151cD. NADPHX detection remains, however, technically challenging (lower intracellular concentrations, lower stability, and earlier elution from the HPLC column) and the remaining of our study focused on the NADHX derivatives. As hydration damage affects the reduced forms of the nicotinamide dinucleotide cofactors and as metabolic regulations have evolved to maintain high NADPH/ NADP ratios (while the opposite is true for NAD), it should be noted here that the analysis of NADPHX formation and its possible effects on cellular function remains a highly relevant topic that should be tackled in future studies. Intriguingly, in the yeast mutants deficient in NAD (P)HX dehydratase, NADHX accumulation only became apparent in postdiauxic phase, a cultivation stage characterized by a switch from aerobic glucose fermentation to ethanol respiration and entry into quiescence. Also, while (S)-and (R)-NADHX were the most abundant derivatives in the NADHX dehydratase mutant ykl151cD in early postdiauxic phase, a further degradation product, cyclic NADHX, dominated in the ykl151cD metabolite profile in later stages. Several hypotheses may be formulated to explain the dynamics of NADHX formation observed here during liquid yeast cultivations. (a) Enzymes catalyzing the formation of NADHX as a side reaction may be upregulated in the postdiauxic phase. So far, GAPDH is the only enzyme for which such a side reaction has been described, based on in vitro assays [1] , but it cannot be excluded that other NAD-dependent enzymes form NADHX as a side product as well. (b) In addition, spontaneous chemical conversion of NADH to NADHX may contribute more or less significantly to the increased damage load in that phase. It is well documented that NADHX formation is accelerated by low pH conditions [3, 7] . Thus, the medium acidification occurring during yeast flask cultivations [43] , as already mentioned above in the context of NADHX epimerization, may progressively decrease the intracellular pH and thereby contribute to increased rates of spontaneous NADH hydration during postdiauxic phase. (c) Another factor that could contribute to the higher NADHX accumulation during postdiauxic phase is the transition from rapidly dividing cells to quiescent cells. Dilution by cell division may limit the Fig. 7 . The NADHX accumulation is accompanied by decreased cell viability, increased glucose uptake, and increased lactate formation in a NAXD deficient human cell line. HAP1 control, NAXD (NAD(P)HX dehydratase) knockout, and NAXE (NAD(P)HX epimerase) knockout cell lines were cultivated for 5 days under standard conditions. (A) Cell number and cell viability were measured using a Nucleocounter NC-3000 at the indicated times after cell seeding. (B-D) Metabolites were extracted at the same time points to measure NAD + and NADHX derivatives by HPLC-UV. Note the different scales used for the y-axis in B and C due to the much lower levels of NADHX detected in NAXE knockout cells. (E) Glucose consumption and lactate production, normalized to cell number, were calculated based on extracellular glucose and lactate concentrations and cell number increase measured between 72 and 96 h after cell seeding. Relative values compared to control cells (glucose consumption and lactate production corresponded to 1.68 AE 0.11 mM/10 6 cells and 2.60 AE 0.18 mM/10 6 cells, respectively) are shown. Consumptions and productions are represented as negative and positive values, respectively. All values shown are means AE SD of three biological replicates. Statistically significant differences between knockout and control cell lines were determined applying an equal variance, unpaired Student's t-test, and are indicated by asterisks (except for (B) , where all the measured NADHX level increases in the NAXD knockout vs. control cells were found to be significant with P ≤ 0.001). No significant differences were found for NAD + levels in the knockout cells compared to the control cells (D); *P < 0.05; **P < 0.01, ***P < 0.001; n.s., not significant.
intracellular accumulation of the damaged cofactor during exponential growth, despite the lack of the repair enzyme. As also suggested by others, damage dilution through cell division is probably a basic strategy to sustain cellular life despite the constant production of potentially harmful side products by all biological processes and may render rapidly dividing cells less dependent on damage control systems (such as metabolite repair enzymes) than nondividing cells [44] [45] [46] . Expression data across several datasets, using the SPELL search engine [26] , indicate higher expression of the YKL151C (and YNL200C) genes during diauxic shift and stationary phase, which further supports the notion that enzymatic repair of NAD(P)H damage may play a more critical role in quiescent cells and/or under respiratory conditions. In our standard experimental conditions, all tested yeast strains had doubling times of about 120 min, reflecting a rapid volume expansion of the cytoplasm. In contrast, the human HAP1 cells used presented doubling times of minimally 8 h, possibly explaining that in those cells NADHX detection was less dependent on the sampling time point. The damage dilution hypothesis could be tested using genetic systems in which the proliferative potential of daughter cells is eliminated, therefore leading to yeast cultivations enriched in aged mother cells [47, 48] . In such systems, NADHX may become detectable at earlier time points than in conventional cultivations. (4) Finally, as the metabolic state of yeast cells in exponential growth (glucose fermentation) is very different from the one in postdiauxic phase (ethanol respiration), it would also be interesting to study the dynamics of NADHX formation upon growth on respiratory carbon sources. Such experiments would be further motivated by recent findings showing an induction of YKL151C expression in yeast cells grown on glycerol as the sole carbon source [49] . Interestingly, a recent study on coenzyme longevity in microorganisms using a dynamic 13 C-labeling approach, completely independently concluded that repair of damaged cofactors (including NAD and NADP) may become 'increasingly important the slower the cells divide' [50] .
NAD(P)HX repair deficiency leads to discrete changes in gene expression and central carbon metabolism in yeast
Transcriptomic and metabolomic profiling of our NAD(P)HX repair-deficient yeast strain allowed to uncover an association between NADHX accumulation and serine synthesis. The increase in intracellular NADHX concentrations during postdiauxic phase was correlated with a strong decrease in expression of a serine catabolic gene (CHA1) and a more than 50% decrease in intracellular serine levels. These observations motivated us to test the effect of NADHX on the enzyme catalyzing the first step of the main serine synthesis pathway in yeast, that is, the only enzyme in this pathway reported to depend on the NAD cofactor. In our attempts to implement these tests, we made another discovery. Given that we were unable to detect the predicted phosphoglycerate dehydrogenase activity of the Ser3 and Ser33 enzymes and given some striking similarities between the E. coli pyridoxal phosphate synthesis pathway and the 3PGA-dependent serine synthesis pathway, we hypothesized that Ser3 and Ser33 may, as the related E. coli PdxB enzyme, catalyze a transhydrogenase reaction. We could indeed show, using LC-MS, that Ser3 and Ser33 oxidize 3PGA in the presence of a-ketoglutarate and in the absence of externally added NAD, with a concomitant production of 2-hydroxyglutarate, qualifying those enzymes as transhydrogenases rather than conventional dehydrogenases. In this study, we have not formally identified the configuration of the 2-hydroxyglutarate product. However, given our previous observation that Ser3 and Ser33 reduce aKG to the D enantiomer of this dicarboxylic acid [37] , this is most likely also the product of the 3PGA-aKG transhydrogenase activity. While this work was ongoing, other investigators independently showed that the Pseudomonas and E. coli phosphoglycerate dehydrogenases (SerA) also actually act as 3PGA-aKG transhydrogenases that produce D-2HG [51, 52] , perfectly corroborating our results with the yeast enzymes. Only relatively few examples of transhydrogenases are known so far. Interestingly, one of them is Dld3 (EC 1.1.99.40), a yeast enzyme for which we recently uncovered that it converts D-2HG to aKG while reducing pyruvate to D-lactate [37] . The Ser3/ Ser33 and Dld3 transhydrogenase activities thus may intimately link serine biosynthesis to the respiratory chain via D-2HG metabolism.
Most relevant for the present study, we then went on to demonstrate that the transhydrogenase activity of Ser3 and Ser33 is potently inhibited by (S)-and (R)-NADHX and to a lesser extent by cyclic NADHX, a further degradation product of NADHX. These findings, obtained with the recombinant enzymes in vitro, strongly suggested that the serine depletion observed in the ykl151cD mutant resulted from inhibition of the main serine synthesis pathway at the level of the first dedicated step by the high intracellular NADHX concentrations. As our in vitro results would predict complete inhibition of 3PGA oxidation at the NADHX concentrations reached in the ykl151cD mutant in postdiauxic phase (more than 100-fold higher than the concentrations needed to completely block the Ser33 activity in vitro), the residual serine pool measured in the mutant most likely derived from the glyoxylate route for serine synthesis [36, 53] . Discovery of the extremely conserved, but apparently not essential, NAD(P)HX repair system [7] raised the question of its physiological relevance. While the recent description of patients presenting with a severe neurometabolic disorder caused by deficiency of this repair system unequivocally demonstrates its essential role in humans, our study provides a first answer in a more mechanistic direction to understand its biological role, pinpointing a metabolic blockage in a central metabolic pathway that would occur if NADHX was left to accumulate. It will be extremely interesting to further investigate the enzymatic properties of phosphoglycerate 'dehydrogenases' (transhydrogenase versus dehydrogenase activity; inhibition by small molecules) from different species across several domains of life to get a deeper understanding of how these properties relate to differences in protein sequence and structure. Ongoing experiments are designed to more deeply characterize the NAD(P)HX inhibition effects on yeast Ser3 and Ser33. Preliminary experiments indicate that the human phosphoglycerate dehydrogenase PHGDH does not catalyze a transhydrogenase reaction and that its NAD-dependent dehydrogenase activity is not inhibited by NADHX.
The Ser3/Ser33 reactions are located at a metabolic branch point, diverting the glycolytic intermediate 3PGA into serine synthesis, and therefore good targets for metabolic regulations. A possible feedback inhibition by serine at this step has already been reported [53] . Interestingly, coregulated expression of YKL151C and its downstream neighboring gene GPM1 (phosphoglycerate mutase converting 3PGA to 2PGA in glycolysis; EC 5.4.2.11) was found very recently [49] . This is mediated by a bidirectional intergenic promoter driving coexpression of GPM1 as well as a YKL151C antisense transcript while repressing expression of the YKL151C sense mRNA, leading to anticorrelated YKL151C and GPM1 transcript levels. During stationary phase and in the presence of nonfermentable carbon sources for instance, GPM1 expression is repressed while YKL151C expression is induced [26, 49, 54] . One could imagine a protective role of Ykl151c for the serine synthesis pathway (by preventing NADHX accumulation), under conditions favoring low phosphoglycerate mutase activity and therefore potentially increased flux from 3PGA toward serine.
CHA1, a serine/threonine deaminase, was (after YKL151C) the gene with the most significantly changed expression (downregulation) in the ykl151cD mutant compared to wild-type. This further supports that the serine synthesis pathway is impaired by NAD (P)HX accumulation. Expression of CHA1 is indeed regulated by serine availability [40] and this has been shown to be mediated by sphingolipids [41] . De novo sphingolipid synthesis is initiated by reaction between serine and palmitoyl-CoA, followed by reduction to sphingoid bases. An increase in newly synthesized sphingoid bases triggers CHA1 expression, leading to an increase in this serine catabolic enzyme, thereby forming a feedforward/feedback loop preventing sphingolipid accumulation by limiting serine levels. In the ykl151cD mutant, decreased CHA1 expression may thus reflect lower sphingoid base levels due to decreased serine availability. More work will be needed to test for altered sphingolipid levels in the ykl151cD strain and potential associated phenotypes. Besides its function as a substrate for de novo sphingolipid synthesis, serine also serves as a proteinogenic amino acid, is a precursor for glycine, cysteine, and phospholipids and feeds into one-carbon metabolism [55] . The latter is of particular interest given that one-carbon metabolism is essential for numerous cellular processes including protein, DNA, and RNA methylation as well as nucleotide biosynthesis [56] . In yeast, the mitochondrial and cytosolic serine hydroxymethyltransferases SHM1 and SHM2 catalyze the reversible conversion of serine to glycine with a concomitant conversion of tetrahydrofolate to 5,10-methylene-tetrahydrofolate, balancing the contribution of serine and glycine to one-carbon metabolism in both cellular compartments [57, 58] . Effects on other cellular processes due to the perturbation in serine synthesis in the ykl151cD mutant are therefore not unlikely and remain to be explored.
NADHX accumulation affects cell viability in human cells, but not in yeast
Despite extensive growth-profiling efforts, we could so far not identify conditions under which the ykl151cD mutant presents slowed growth. This is consistent with previous investigations, which also did not reveal any overt growth phenotypes for NAD(P)HX repairdeficient mutants in E. coli, yeast, and A. thaliana [8, 10, 19, 20] . However, potassium limitation and ethanol/osmotic stress in NAD(P)HX dehydratase knockout Bacillus subtilis strains led to prolonged lag phases and reduced viability [22] , suggesting that this repair enzyme is beneficial for stress adaptation under certain conditions. Accordingly, the yeast NAD(P)HX dehydratase and/or epimerase are upregulated under several stress conditions such as heat stress, oxidative stress, and starvation [26, 49, 54] . In our human HAP1 cell line deficient in the NAD(P)HX dehydratase, we observed a decrease in cell viability upon prolonged cultivation already under standard conditions. While NAD(P)HX epimerase deficiency did not lead to decreased viability in our cell culture model, patients with mutations in the NAXE gene have recently been shown to suffer from a severe neurometabolic condition, triggered by febrile episodes and leading to early childhood death [23, 24] .
In contrast to the yeast system, we measured NADHX accumulation in both the NAXD and NAXE HAP1 KO cells, but much higher levels were found in the NAXD KO cell line. In addition, NAXD KO cells, but not NAXE KO cells, showed higher glucose consumption and lactate formation. Elevated lactate levels and impaired mitochondrial function (decrease in complex I activity and pyruvate oxidation) were reported in the cerebrospinal fluid and in muscle biopsies, respectively, of NAXE-deficient subjects [24] . Fibroblast cell lines from these subjects also contained higher NADHX levels [24] . Taken together, our cell culture results and the results obtained with patient-derived material suggest that NAD(P)HX repair deficiency leads to perturbed mitochondrial energy metabolism (with a compensatory increase in glycolytic flux). While deficient NAD(P)HX epimerase activity has fatal consequences at the organismal level, the effects on cultured cell lines are more subtle ( [24] and this study). In contrast, a loss of NAD(P)HX dehydratase activity leads to pronounced perturbations in cultured cells as described in this study. Mutations in this enzyme have not yet been reported in human subjects. The molecular mechanism linking NAD(P)HX repair deficiency and mitochondrial dysfunction remains to be elucidated; our NAD(P)HX dehydratase KO cell line will be a useful model in that endeavor.
The onset of neurological symptoms in NAXE-deficient subjects upon fever episodes is consistent with the thermolability of NAD(P)H and the higher NAD (P)HX formation rates from NAD(P)H in vitro with increasing temperature [7] . Also in line with this, in our NAD(P)HX dehydratase KO yeast strain, cultivation at higher temperature led to increased NADHX accumulation and more pronounced NAD + depletion. In the human NAD(P)HX repair-deficient cells, we could not detect changes in NAD + levels compared to control cells. It will be important to consolidate these results because a crucial question in view of finding treatment options for NAD(P)HX repair-deficient subjects is whether the symptoms are mostly caused by a decrease of the functional pools of the NAD(P) cofactors or by toxic effects of the abnormal NAD(P)HX metabolites that accumulate. The former cause may be more straightforward to address, notably by supplementation of NAD precursor vitamins such as nicotinic acid, nicotinamide, or nicotinamide riboside [59] . Unlike for the yeast model, we could not detect any changes in serine levels in our NAD(P)HX repair-deficient human cell lines. However, as for the yeast model, combined transcriptomic and metabolomic profiling of the human NAXD KO cells may allow identification of metabolic blockages caused by NADHX or NADPHX and thereby guide further efforts to find treatment strategies for NAD(P)HX repair-deficient subjects.
Materials and methods
Materials
Reagents, of analytical grade whenever possible, were purchased from Sigma Aldrich (Bornem, Belgium), if not otherwise indicated.
Generation of mutant and transformed yeast strains
The Saccharomyces cerevisiae strains used in this study are listed in Table S4 . All strains were isogenic to the haploid reference strain BY4741, originating from the EURO-SCARF collection (Frankfurt, Germany). The double knockout strain ykl151cDynl200cD was generated by mating the corresponding haploid single mutant strains of opposing mating types, followed by sporulation on acetatecontaining plates (10 gÁL À1 potassium acetate, 20 gÁL À1 agar) and tetrad dissection. Gene deletions in the knockout strains were confirmed by PCR analysis (see Table S5 for primer sequences). The coding sequences of the YKL151C, TDH1, TDH2, and TDH3 genes were PCR-amplified using primers containing attB sites (Table S5 ) and cloned into the pDONR221 vector (Invitrogen, Erembodegem, Belgium) using the BP clonase II enzyme mix (Invitrogen) according to the manufacturer's instructions. The genes were then shuttled from the resulting Entry vectors to the pAG416-GPD-ccdB Destination vector (AddGene ID #14148) or the pAG426-GAL1-ccdB Destination vector (AddGene ID #14155) using the LR clonase II enzyme mix (Invitrogen) and the final Expression vectors were transformed into the desired yeast strains as described previously [37] .
Yeast cultivation
Yeast strains were cultivated in minimal defined medium (6.7 
Human cell culture and viability assay
Control, NAXD knockout, and NAXE knockout HAP1 cell lines were obtained from Horizon Discovery Group plc (Vienna, Austria) ( Table S4 ). The provided knockout cell lines were generated by introducing a frameshift in the NAXD or NAXE genes using the CRISPR/Cas9 technology, resulting in an early truncation of the proteins. The genetic mutations were confirmed by Sanger sequencing (see Table S5 for primer sequences). Cells were maintained in IMDM medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin (Thermo Fisher Scientific, Erembodegem, Belgium) at a constant CO 2 level of 5% and at 37°C. Cells were passaged after maximally 96 h or before reaching a confluency of 85%. Medium was refreshed earlier if necessary. For cell culture experiments, cells were trypsinized (Thermo Fisher Scientific), counted (Nucleocounter NC-3000 from ChemoMetec, Kaiserslautern, Germany), and seeded (250 000 cells in 2 mL medium per well) into standard flat-bottom 6-well plates (Nunclon Delta Surface, Thermo Fisher Scientific). Culture medium was not changed until 96 h after seeding, that is, only for the last sampling point after 120 h cells were supplied with new medium). Cell viability was determined using the Nucleocounter NC-3000 by mixing trypsinized cells at appropriate dilutions with a dye containing acridine orange and 4 0 ,6-diamidin-2-phenylindole (Solution 13 AO - [12] [13] [14] [15] [16] [17] [18] Primers (Invitrogen) were incubated for 10 min at 70°C and 10 min at 25°C to reduce hairpin formation. First-Strand cDNA synthesis was performed in a mixture (60 lL) containing the denatured RNA and the primers, 19 reaction buffer from the SuperScript First-Strand Synthesis System (Invitrogen), 10 mM DTT, 0.5 mM dCTP/ dATP/dGTP, 0.4 mM dTTP, 0.1 mM dUTP, 20 lgÁmL
DAPI, ChemoMetec
À1
Actinomycin D, and 30 UÁlL À1 SuperScript II Reverse Transcriptase (Invitrogen). The mixture was incubated for 60 min at 42°C and for 10 min at 70°C. RNA was degraded by addition of 3 lL of both RNaseH (30 Units, Epicentre, Madison, USA) and RNase Cocktail TM (containing 30 Units RNase T1 and 1.5 Units RNase A, Thermo Fisher Scientific) and subsequent incubation at 37°C and 70°C for 20 min each. The remaining DNA was purified using the AMPure XP reagent (Beckman Coulter) according to the manufacturer's instructions. For DNA fragmentation, biotinylation, and labeling, the GeneChip WT Terminal labeling kit (Thermo Fisher Scientific) was used starting from 5.5 lg cDNA. Finally, labeled cDNA was hybridized to the Affymetrix S. cerevisiae tiling array (6.5 million 25-mer probes with an eight nucleotide offset between each probe, PN 520055, Affymetrix, Thermo Fisher Scientific) using the GeneChip Hybridization, Wash and Stain kit (Affymetrix, Thermo Fisher Scientific). Scanning of the chips was performed with an Affymetrix 3000 7G scanner. For raw data treatment, transcription intensity signals were corrected for probe-specific parameters through normalization with genomic DNA from Saccharomyces cerevisiae S288c and probes were mapped to the yeast genome based on the annotation from Xu et al. [31, 32] . Tiling array probe intensities were aggregated to gene expression level as described in [60] .
Two genes with highly significantly changed expression as indicated by the tiling arrays were validated by qRT-PCR. For this, cDNA was synthesized using 1.5 lg total RNA and random hexamer primers with the RevertAid H Minus First-Strand cDNA Synthesis Kit (Invitrogen) according to the manufacturer's instructions. The qRT-PCR reactions were performed in LightCycler 480 Multiwell plates (384 wells, Roche, Luxembourg, Luxembourg) using the iQ SYBR Green Supermix (BioRad, Temse, Belgium) with 3 pmol of each the gene-specific forward and reverse primers and 2 lL cDNA (1 : 20 dilution) in a total volume of 20 lL. The primers used are listed in Table S5 . Fold changes were calculated based on three biological replicates using the 2 ÀDDCT method and ALG9 as the reference gene, which showed little variation between replicates and during time course experiments [61] .
Metabolite extraction and sample preparation for metabolite analyses
Yeast metabolite extracts were generated using two different methods. For targeted analysis of NAD derivatives only, a method adapted from Sporty et al. [25] was used.
In our experiments, we adapted the volume of culture aliquots to be extracted to always correspond to a total of five OD units, assuming a linear correlation between biomass and OD. Cells were washed once with 2 mL of 0.9% (w/v) NaCl before resuspending them in 600 lL extraction buffer (50 mM ammonium acetate, pH 7.0). Cells were blasted for 2 9 30 sec with a 60 sec break in a Precellys Cell Homogenizer (VWR) connected to a Cryolys cooling unit (VWR) in 2-mL re-enforced bead-beating tubes (VWR) filled with glass beads to the meniscus of the cell suspension. After two additional washing steps of the glass beads and one of the cell debris with extraction buffer and acetonitrile (1 : 3; v:v) [25] , extracts were transferred to tubes containing 6 mL chloroform and incubated for 20 min on ice to remove nonpolar compounds. After centrifugation, the upper aqueous phase was freeze-dried in a LabConco lyophilizer (cold trap temperature À82°C, chamber vacuum 0.002 mbar, VWR) and stored at À80°C until analysis. For a broader metabolite profiling (amino acids, organic acids, and NAD derivatives), samples were generated as described in [37] with two minor changes: the ratio between biovolume and extraction fluid was reduced to 1 : 50 (v:v) and the extraction buffer [50% methanol, 50% TE buffer (10 mM TrisHCl, 1 mM EDTA, pH 7.0)] and chloroform were bubbled with N 2 to reduce spontaneous metabolite oxidation. The resulting filtered extracts were injected directly for LC-MS/MS analysis of amino acids and organic acids, but lyophilized and stored as described above for subsequent analysis of NAD derivatives by HPLC. In this approach, a Multisizer Z3 (Beckman Coulter, Villepinte, France) was used to determine cell concentration and single cell volume in the culture aliquots and this information was used to determine the total biovolumes and to calculate intracellular metabolite concentrations for each sample.
For metabolite extraction from adherent human-cultured cells, the extraction method used in [37] was adapted as follows: cells were washed with 2 mL 0.9% (w/v) NaCl and then extracted by scraping them into 600 lL N 2 -bubbled extraction buffer (50% methanol, 50% TE buffer) while maintaining the 6-well plate on an ice-cold plate (CoolSink Ò XT 96F, Biocision). Lysates were transferred to tubes containing 600 lL of ice-cold chloroform, followed by 30-min shaking at À20°C and centrifugation. The upper polar phase was filtered into fresh tubes and stored at À80°C until analysis.
Metabolite analyses by HPLC and LC-MS/MS
To measure and quantify NAD + , NADH, and NADHX derivatives ((S)-, (R)-, and cyclic NADHX), a previously published HPLC-UV method was adapted [7] . Measurements were performed on a Shimadzu Nexera UHPLC system equipped with two LC-30AD pumps, a SIL-30AC-cooled autosampler, and an SPD-M20A photo-diode array detector. Before analysis, dried samples were resuspended in 40-75 lL of 50 mM ammonium acetate, pH 7.0. Baseline separation of the compounds was achieved on a Polaris C18-A column (150 9 4.6 mm, 3.0 lm particle size, 180 A pore size, Agilent, Diegem, Belgium) connected to a Metaguard Polaris C18-A precolumn (for 4.6 mm ID columns, Agilent) using 50 mM ammonium acetate, pH 7.0 as the mobile phase and acetonitrile (ACN) for compound elution according to the following gradient profile: 0-20 min, 0-5% ACN; 20-27 min, 5-90% ACN; 27-28 min, 90-0% ACN, and re-equilibration for 7 min at 0% ACN before injecting the next sample. Detection was performed at 279 nm for NAD + and NADHX and 340 nm for NADH.
External calibration curves with NAD + , NADH, and NADHX standards (0.7-100 lM) were used for quantification. The (S)-, (R)-, and cyclic NADHX standards were prepared using a preparative HPLC method adapted from [7] . The NADH derivatives were separated on a Luna C18 (2) column (250 9 10.0 mm, 5.0 lm particle size, 100 A pore size, Phenomenex, Utrecht, Netherlands) at a constant flow rate of 4 mLÁmin À1 with a mobile phase containing 10 mM ammonium acetate, pH 7.0 (elution gradient: 0-25 min, 0.1-5% ACN; 25-26 min, 5-0.1% ACN, and re-equilibration for 9 min at 0.1% ACN). Peak fractions containing the highest amounts of the NADHX derivative of interest were collected and dried in a lyophilizer after adjusting the pH to 8.0 with NaOH. Reconstituted fractions were used for the phosphoglycerate transhydrogenase inhibition assays in addition to serving as standards for the HPLC analyses. The (S)-, (R)-, and cyclic NADHX concentrations in the standard solutions were determined spectrophotometrically using previously published extinction coefficients (e 290 = 13 500 M To quantify all 20 physiological amino acids, a targeted LC-MS/MS method was used. Measurements were performed on a Shimadzu Nexera XR LC 20AD coupled to a Sciex API4000 Qtrap mass spectrometer equipped with an electrospray ion source. Nitrogen was supplied by an NMG33 generator (CMC, Eschborn, Germany). Absolute concentrations were calculated based on external calibration curves prepared in 50% LC-MS-grade methanol. Measurement values were normalized to 13 C-labeled internal standards extracted by the cold methanol method described above from yeast cells grown on 13 C-glucose using isotope dilution mass spectrometry, except for glycine, alanine, cysteine, threonine, lysine, and aspartate (no 13 C-standard available). Analyte separation was achieved by hydrophilic interaction chromatography using a SeQuant ZIC Ò -HILIC columm (150 9 2.1 mm, 3.5 lm particle size, 100 A pore size, Merck, Overijse, Belgium) equipped with a SecurityGuard ULTRA precolumn (UHPLC HILIC for 2.1 ID Columns, Phenomenex) at a constant flow rate of 0.25 mLÁmin À1 and a temperature of 25°C. Target metabolites were eluted using the following gradient, where solvent A was water:acetonitrile:formic acid (98.9 : 1 : 0.1) and solvent B was acetonitrile:water:formic acid (98.9 : 1 : 0.1): 0-2 min, isocratic at 90% B; 2-7 min, 90-20% B; 7-10 min, 20-10% B; 10-12 min, isocratic at 10% B; 12-12.1 min, 10-90% B, followed by a re-equilibration for 8.9 min at starting condition. The autosampler was kept cold at 4°C. 1 lL of sample was injected and mass spectral data were acquired in positive scheduled multiple reaction monitoring mode. Source settings and mass transitions are given in Table S6 . For analysis of metabolites connected to the serine synthesis pathway (3-phosphoserine, 3-phosphoglycerate, a-ketoglutarate, and 2-hydroxyglutarate), a second targeted LC-MS/MS method was applied using the same instrumental setup. Chromatographic separation was achieved on a C18EVO column (150 9 2.1 mm, 3.5 lm particle size, 100 A pore size, Phenomenex) connected to a guard column (SecurityGuard ULTRA cartridge, UHPLC C18EVO for 2.1 mm ID columns, Phenomenex), keeping the column oven temperature at 55°C and using a flow rate of 0.2 mLÁmin À1 in gradient mode where solvent A was water:formic acid (99.9 : 0.1) and solvent B was methanol:formic acid (99.9 : 0.1), according to the following profile: 0-2 min, isocratic at 0% B; 2-4 min, 0-10% B; 4-6.5 min, 10-95% B; 6.5-10 min, isocratic at 95% B, 10-10.1 min, 95% to 0% B, followed by a re-equilibration of 9.9 min at starting condition. 2 lL of sample was injected and the autosampler was kept cold at 4°C. Mass spectral data were acquired in negative multiple reaction monitoring mode. Source settings and mass transitions are given in Table S6 .
Expression and purification of yeast Ser3 and Ser33 and of human phosphoserine transaminase (PSAT1) and 3-phosphoglycerate dehydrogenase (PHGDH)
The SER3-and SER33-coding sequences were cloned into bacterial expression plasmids as described previously [37] . The pET15b-PSAT1 and pET28-PHGDH expression vectors were kindly provided by Emile Van Schaftingen and Guido Bommer, respectively (de Duve Institute, Brussels). All plasmids were verified by Sanger sequencing and chemically transformed into E. coli BL21 (DE3) cells (Thermo Fisher Scientific). Bacterial cultivation and protein expression were carried out as previously described [37, 63] . The final isopropyl b-D-1-thiogalactopyranoside concentrations for induction of protein expression were 0.5 mM for PHGDH, 1 mM for PSAT1, and 0.1 mM for Ser3 and Ser33. Subsequent purification steps were performed on an € AKTA protein purifier (GE Healthcare, Diegem, Belgium) using 1 mL HisTrap columns (GE Healthcare, Uppsala, Sweden) for nickel-affinity purification and two HiTrap Desalting columns (5 mL, GE Healthcare, Uppsala, Sweden) connected in series for desalting. Purified and desalted protein fractions were analyzed by SDS/PAGE and the protein concentration was measured using a Bradford assay (BioRad). Glycerol was added to the active fractions at a final concentration of 10% (v/v) before storage at À80°C.
Enzymatic activity assays
The transhydrogenase activity of Ser3, Ser33, and PHGDH was measured by incubating the enzyme in a reaction mixture containing 25 mM HEPES, pH 7.1, 1 mM MgCl 2 , 1 mM DTT, 5 lM pyridoxal-5 0 -phosphate, 50 lM 3-phosphoglycerate, 200-250 lM L-glutamate, 25 lM a-ketoglutarate, and 50-100 lgÁmL À1 PSAT1 at 30°C, if not indicated otherwise. After a brief preincubation of the mixture at 30°C, the reaction was started by adding the enzyme at a final concentration of 25-40 lgÁmL À1 for Ser33 and 20 lgÁmL À1 for PHGDH. After 5-10 min, aliquots were heat-inactivated at 95°C for 5 min, filtered (4 mm diameter filters, regenerated cellulose, 0.2 lM pore size, Phenomenex) into glass vials and analyzed by LC-MS/MS as described above for the serine synthesis pathway intermediates. For inhibition assays, (S)-, (R)-, and cyclic NADHX as well as NAD + were added to the reaction mixture to final concentrations between 0 and 25 lM. For these inhibition studies, a mock preparative HPLC without NADHX injection was run to collect fractions at the retention times of the different NADHX derivatives; those fractions were added instead of the corresponding NADHX standards to the reaction mixture for negative control assays. Enzymatic activities were calculated based on the time-dependent amount of 2-hydroxyglutarate formed; incubation times were chosen so as to remain within the linear product formation frame. Control reactions run in the absence of the 3PGA substrate were used for background correction of the activity measurements. All assays were performed in triplicate if not indicated otherwise. 3PGA dehydrogenase activity of human PHGDH was measured spectrophotometrically at a wavelength of 340 nm to follow NADH formation. 
Small molecule assays
Glucose and lactate levels in spent human cell culture media were measured using a YSI 2950D biochemistry analyzer (Yellow Springs Instruments, Yellow Springs, Ohio, USA) as described in [37] and according to the manufacturer's instruction.
Statistical analysis
An equal variance, unpaired Student's t-test was applied to gene expression, metabolite concentration, and LC-MS(/MS) signal intensity data to determine significant differences (*P < 0.05; **P < 0.01; ***P < 0.001; n.s., not significant), if not indicated otherwise. For the differential pathway analysis of the tiling array results, a multiple hypothesis testing adjustment was additionally performed to increase the robustness of the statistical results.
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